세계의 모바일 헬스(mHealth) 시장 전망(-2030년) : 제품, 용도, 최종 사용자 및 지역별 분석

According to Stratistics MRC, the Global Mhealth Market is accounted for $92.1 billion in 2023 and is expected to reach $233.1 billion by 2030 growing at a CAGR of 14.2% during the forecast period. The Mhealth well known as mobile health is the practice of using mobile devices like smartphones and tablets for healthcare delivery, monitoring, and information dissemination. Its uses include remote patient monitoring, medication adherence reminders, health data tracking, telemedicine consultations, and health information access.

According to the GSMA State of Mobile Internet Connectivity Report 2020, approximately 50% of the global population had access to the mobile internet connectivity by the end of 2019. An increase of 250 million mobile internet users was recorded from 2018 to 2019.

Market Dynamics:

Driver:

Growing chronic disease rates

With conditions like diabetes, cardiovascular diseases and respiratory disorders on the rise globally there is a growing need for innovative healthcare solutions that empower individuals to manage and monitor their health effectively. Mhealth offers a range of applications, from mobile apps providing personalized health information and medication reminders to wearable devices enabling continuous health tracking. These technologies facilitate remote patient monitoring, early detection of health issues and prompt intervention, contributing to improved disease management and overall healthcare outcomes.

Restraint:

Data breaches and cybersecurity threats

With the sensitive nature of health data, ensuring robust protection against breaches and unauthorized access is paramount. The evolving landscape of cyber threats demands continuous investment in cutting-edge security measures, encryption protocols, and stringent access controls. Maintaining the confidentiality, integrity, and availability of patient information is crucial, necessitating a fine balance between accessibility and fortification against potential cyber intrusions, requiring ongoing vigilance and adaptive strategies to safeguard Mhealth platforms and user data.

Opportunity:

Data analytics and health records

Innovations in managing, analyzing, and securing health data promise enhanced patient care, predictive insights, and streamlined processes. Leveraging data analytics allows for comprehensive understanding of patient trends, treatment outcomes, and resource allocation, enabling personalized healthcare solutions. With the integration of advanced technologies and artificial intelligence, healthcare providers gain the ability to make data-driven decisions, improving diagnostics, treatment plans, and preventive care. This field's growth is fueled by the quest for more efficient, accurate, and secure methods of handling patient information within the healthcare ecosystem.

Threat:

Limited connectivity and infrastructure

This limitation impedes the seamless functionality of mHealth solutions, hindering their accessibility and effectiveness for a significant portion of the population. Without robust connectivity, the real-time exchange of health data, remote consultations, and the use of health apps become challenging. Addressing this threat demands substantial investment in expanding technological infrastructure, improving connectivity, and designing mHealth solutions that can operate effectively in low-bandwidth environments to ensure equitable access to healthcare services across diverse geographical and socio-economic landscapes.

COVID-19 Impact:

The COVID-19 pandemic had a profoundly positive impact on the mHealth market. As healthcare systems worldwide faced unprecedented challenges, mHealth solutions emerged as a critical lifeline. Telemedicine and remote monitoring became essential for patient care, reducing the risk of virus transmission and easing the strain on healthcare facilities. The pandemic accelerated the adoption of mHealth technologies, fostering a more receptive environment for virtual consultations, health monitoring, and digital health records. This shift in mindset and behavior is likely to have a lasting impact, with mHealth poised to play an integral role in the future of healthcare delivery, making it more accessible, convenient, and efficient.

The apps segment is expected to be the largest during the forecast period

The apps segment is expected to have a lucrative growth. These machines are designed to perform intricate dicing and cutting processes with minimal human intervention. They offer benefits like increased efficiency, precision, and consistency, reducing the potential for human error. Fully automatic dicing machines incorporate advanced robotics, software, and sensors to handle various materials and cutting requirements. Their adoption is driven by the need for higher productivity and yield rates, particularly in the semiconductor industry. As technology continues to advance, fully automatic dicing machines are expected to play a crucial role in meeting the growing demand for miniaturized and high-performance electronic components.

The diagnostics and treatment segment is expected to have the highest CAGR during the forecast period

The diagnostics and treatment segment is anticipated to witness the highest CAGR growth during the forecast period. Advanced diagnostic tools, often integrated into mobile apps, enable users to perform self-assessments, analyze symptoms, and even conduct certain medical tests remotely. Additionally, these solutions utilize AI and machine learning to aid in accurate diagnosis and personalized treatment recommendations. This convergence of technology with healthcare empowers individuals to proactively manage their health, offering early detection, timely interventions, and tailored treatment plans, thus revolutionizing the traditional approach to diagnostics and treatment, ultimately fostering better health outcomes.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share, driven by advanced technological infrastructure, robust healthcare systems, and a culture embracing digital innovation. The region showcases a prolific landscape of mHealth solutions, from telemedicine platforms to sophisticated health monitoring devices. The adoption of wearable technology, coupled with a high smartphone penetration rate, fosters a receptive environment for health apps and remote consultations.

Region with highest CAGR:

The Asia Pacific region plays a significant role in the market and is projected to have the highest CAGR over the forecast period. With diverse healthcare needs and vast populations, this region showcases immense potential for mHealth solutions. Innovations span telehealth services, remote patient monitoring, and health-focused apps catering to various health concerns. The proliferation of affordable mobile technology, coupled with supportive government initiatives and growing digital literacy, fosters a fertile ground for mHealth expansion.

Key players in the market

Some of the key players in Mhealth market include: Allscripts Healthcare Solutions, Apple, Inc., Boston Scientific Corporation, Fitbit, Google, Inc., Koninklijke Philips N.V., Medtronic plc, Omron Corporation., Qualcomm Technologies, Inc., Samsung Electronics Co. Ltd., Teladoc Health, Inc., Telefonica S.A. and Vodafone Group.

Key Developments:

In March 2023, Astellas Pharma Inc. announced that it has entered into an agreement ("the Agreement") with Roche Diabetes Care Japan Co., Ltd. for the development and commercialization of Roche Diabetes Care's world-renowned Accu-Chek Guide Me blood glucose monitoring system with advanced accuracy as a combined medical product with BlueStar.

In November 2022, OMRON Healthcare announced partnership with CardioSignal to innovate early cardiovascular disease detection and remote patient monitoring at scale. As a first result of the collaboration, CardioSignal mobile health apps integrated into OMRON connect to detect signs of atrial fibrillation. Users simply lie down and place the mobile phone in the center of the chest. Measurement starts automatically and the user receives a notification of the possibility of atrial fibrillation. This service is available in OMRON Connect.

Products Covered:

• Wearables
• Apps
• Other Products

Applications Covered:

• Education and Awareness
• Diagnostics and Treatment
• Disease and Epidemic Outbreak Tracking
• Remote Monitoring
• Other Applications

End Users Covered:

• Physicians
• Research Centers
• Pharmacies
• Biopharmaceutical Companies
• Government
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Mhealth Market, By Product

• 5.1 Introduction
• 5.2 Wearables
  • 5.2.1 BP Monitors
  • 5.2.2 Glucose Meters
  • 5.2.3 Pulse Oximeters
  • 5.2.4 Sleep Apnea Monitors
  • 5.2.5 Cardiac Monitors
  • 5.2.6 Hemodynamic Monitors
  • 5.2.7 Neurological Monitors
  • 5.2.8 Other Wearables
• 5.3 Apps
  • 5.3.1 Medical Apps
    • 5.3.1.1 Personal Health Record Apps
    • 5.3.1.2 Medication Management Apps
    • 5.3.1.3 Disease Management Apps
    • 5.3.1.4 Other Medical Apps
  • 5.3.2 Fitness Apps
    • 5.3.2.1 Exercise & Fitness
    • 5.3.2.2 Diet & Nutrition
    • 5.3.2.3 Lifestyle & Stress
    • 5.3.2.4 Other Fitness Apps
• 5.4 Other Products

6 Global Mhealth Market, By Application

• 6.1 Introduction
• 6.2 Education and Awareness
• 6.3 Diagnostics and Treatment
• 6.4 Disease and Epidemic Outbreak Tracking
• 6.5 Remote Monitoring
• 6.6 Other Applications

7 Global Mhealth Market, By End User

• 7.1 Introduction
• 7.2 Physicians
• 7.3 Research Centers
• 7.4 Pharmacies
• 7.5 Biopharmaceutical Companies
• 7.6 Government
• 7.7 Other End Users

8 Global Mhealth Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Allscripts Healthcare Solutions
• 10.2 Apple, Inc.
• 10.3 Boston Scientific Corporation
• 10.4 Fitbit
• 10.5 Google, Inc.
• 10.6 Koninklijke Philips N.V.
• 10.7 Medtronic plc
• 10.8 Omron Corporation.
• 10.9 Qualcomm Technologies, Inc.

11 Samsung Electronics Co. Ltd.

• 11.1 Teladoc Health, Inc.
• 11.2 Telefonica S.A.
• 11.3 Vodafone Group